ARCHIVES

AVEO’s Tivozanib Sunk by Fundamental Flaw: Higher Overall Survival in the Control Arm

This article is from The Cancer Letter archive.

Vol. 39 No. 18 | May 8, 2013

Download PDF Visit The Full Archive

Related Articles

Bevacizumab And Irinotecan May Increase Survival Of GBM

October 26, 2007

Breast Cancer Task Force Must Take More Active Role In RFP Development, New Chairman Insists

November 14, 1975

In Brief: NCAB To Hear Report On Controversial Special Virus Cancer Program March 19; Centers, Bladder Project Also On Agenda

March 8, 1974

Four RFAs Released For RM Program

November 6, 1981

In Brief: UICC Publishes International directory Of Cancer Centers; HSAs Still Worry NCI

January 7, 1977

NIH To Give 3 Percent Increase to Grants

March 20, 2009